BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 3, 2009
View Archived Issues
Bayer Schering Pharma and AstraZeneca claim GR ligands as anti-inflammatory agents
Read More
Vasopressin V1b receptor ligands under development at Abbott
Read More
Bristol-Myers Squibb discovers new NS5B polymerase inhibitors for the treatment of HCV
Read More
Studies assess ghrelin in healthy men, frail older women, hip replacement patients
Read More
Merck Research Laboratories describes orally active very-late antigen-4 antagonists
Read More
Phase II activity of masitinib with gemcitabine in pancreatic cancer leads to phase III study
Read More
Preclinical antihypertensive activity seen with SAR-407899
Read More
Pharming presents results from final analysis of Rhucin studies
Read More
CombinatoRx and Neuromed enter into merger agreement
Read More
Pfizer discontinues phase III trial of Sutent in metastatic colorectal cancer
Read More
Inovio signs collaboration agreement with NML and UP to evaluate H1N1 vaccines
Read More
Vical reports results from two parallel animal studies of DNA vaccine against A/H1N1
Read More
Medinet and the University of Tokyo Hospital start collaborative clinical study
Read More
FDA approves Multaq for atrial fibrillation and atrial flutter
Read More
Astellas and Maxygen sign joint venture agreement for multiple protein pharmaceuticals
Read More
Amira reports initial results from phase I clinical study of AM-211 for respiratory diseases
Read More
Biogen and Acorda sign collaboration and license agreement for MS drug Fampridine-SR
Read More
FDA makes initial regulatory determination on Novartis' BLA for Menveo vaccine
Read More
BioSante and Cell Genesys sign definitive merger agreement
Read More
Study results for Intermezzo in middle-of-the-night awakenings detailed
Read More
Takeda presents further data on ramelteon efficacy in chronic insomnia
Read More
Lupin acquires worldwide rights to Collegium's AllerNaze
Read More
Chelsea Therapeutics completes enrollment in phase III trial of droxidopa in NOH
Read More
Repros scheduled to discuss phase III clinical program for Proellex with the FDA
Read More
Provectus completes patient accrual in phase II PH-10 study for atopic dermatitis
Read More